Nuveen Asset Management, LLC Altimmune, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 234,430 shares of ALT stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

234,430

Previous 665,058 64.75%

Holding current value

$2.03 Million

Previous $4.42 Million 67.46%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $2.37 Million - $3.49 Million	-430,628 Reduced 64.75%	234,430 $1.44 Million
Q2 2024 Aug 09, 2024	SELL	$5.91 - $10.23 $1.47 Million - $2.54 Million	-247,942 Reduced 27.16%	665,058 $4.42 Million
Q1 2024 May 13, 2024	SELL	$8.22 - $13.81 $6.69 Million - $11.2 Million	-814,316 Reduced 47.14%	913,000 $9.29 Million
Q4 2023 Feb 14, 2024	SELL	$2.14 - $11.62 $3.68 Million - $20 Million	-1,719,462 Reduced 49.89%	1,727,316 $19.4 Million
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $29,210 - $41,989	-12,171 Reduced 0.35%	3,446,778 $8.96 Million
Q2 2023 Aug 14, 2023	BUY	$3.45 - $5.97 $658,563 - $1.14 Million	190,888 Added 5.84%	3,458,949 $12.2 Million
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $8,790 - $35,309	2,098 Added 0.06%	3,268,061 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $455,030 - $856,436	52,063 Added 1.62%	3,265,963 $53.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $1.6 Million - $3.35 Million	149,620 Added 4.88%	3,213,900 $41 Million
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $712,840 - $2.13 Million	-180,924 Reduced 5.58%	3,064,280 $35.9 Million
Q1 2022 May 16, 2022	BUY	$5.9 - $9.45 $5.6 Million - $8.97 Million	949,372 Added 41.35%	3,245,204 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $12.9 Million - $18.6 Million	1,490,012 Added 184.91%	2,295,832 $19.4 Million
Q3 2021 Nov 12, 2021	BUY	$8.43 - $16.81 $4.78 Million - $9.54 Million	567,253 Added 237.78%	805,820 $12.3 Million
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $2.35 Million - $3.93 Million	238,567 New	238,567 $2.35 Million

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $426M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Altimmune, Inc. Transaction History